Shares of Moderna Inc. /zigman2/quotes/205619834/composite MRNA +2.21% slid 3.19% to $119.69 Monday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP -0.59% falling 0.60% to 10,802.92 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.20% falling 1.11% to 29,260.81. This was the stock's fourth consecutive day of losses. Moderna Inc. closed $314.31 below its 52-week high ($434.00), which the company reached on September 27th.
The stock underperformed when compared to some of its competitors Monday, as AbbVie Inc. /zigman2/quotes/202428675/composite ABBV +0.22% fell 1.29% to $141.21, Amgen Inc. /zigman2/quotes/209157011/composite AMGN +0.19% fell 0.04% to $226.87, and AstraZeneca PLC ADR /zigman2/quotes/200304487/composite AZN +0.44% fell 2.86% to $53.02. Trading volume (3.7 M) remained 974,092 below its 50-day average volume of 4.7 M.